Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apelin as a Potential Treatment for Chronic Kidney Disease: The AlPaCKa Study

NCT03956576 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.

NCT NCT03956576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03956576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apelin as a Potential Treatment for Chronic Kidney Disease: The AlPaCKa Study
Lead sponsor
University of Edinburgh
Phase
Not applicable
Overall status
Completed
Start date
February 4, 2020
Completion date
December 14, 2022
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, chronic kidney diseases, endothelial dysfunction